These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28495061)

  • 1. High-risk cardiac surgery as an alternative to transplant or mechanical support in patients with end-stage heart failure.
    Kawajiri H; Manlhiot C; Ross H; Delgado D; Billia F; McDonald M; Rao V
    J Thorac Cardiovasc Surg; 2017 Aug; 154(2):517-525. PubMed ID: 28495061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of heart transplantation performed after ventricular assist device compared with standard heart transplantation.
    Petroni T; D'Alessandro C; Combes A; Golmard JL; Brechot N; Barreda E; Laali M; Farahmand P; Varnous S; Weber P; Pavie A; Leprince P
    Arch Cardiovasc Dis; 2019; 112(8-9):485-493. PubMed ID: 31353279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure.
    Di Salvo TG; Mathier M; Semigran MJ; Dec GW
    J Am Coll Cardiol; 1995 Apr; 25(5):1143-53. PubMed ID: 7897128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
    Daneshmand MA; Rajagopal K; Lima B; Khorram N; Blue LJ; Lodge AJ; Hernandez AF; Rogers JG; Milano CA
    Ann Thorac Surg; 2010 Apr; 89(4):1205-9; discussion 1210. PubMed ID: 20338335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial left ventriculectomy and mitral valve repair for end-stage congestive heart failure.
    McCarthy JF; McCarthy PM; Starling RC; Smedira NG; Scalia GM; Wong J; Kasirajan V; Goormastic M; Young JB
    Eur J Cardiothorac Surg; 1998 Apr; 13(4):337-43. PubMed ID: 9641329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High early event rates in patients with questionable eligibility for advanced heart failure therapies: Results from the Medical Arm of Mechanically Assisted Circulatory Support (Medamacs) Registry.
    Ambardekar AV; Forde-McLean RC; Kittleson MM; Stewart GC; Palardy M; Thibodeau JT; DeVore AD; Mountis MM; Cadaret L; Teuteberg JJ; Pamboukian SV; Cantor RS; Lindenfeld J
    J Heart Lung Transplant; 2016 Jun; 35(6):722-30. PubMed ID: 26987599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term use of a left ventricular assist device for end-stage heart failure.
    Rose EA; Gelijns AC; Moskowitz AJ; Heitjan DF; Stevenson LW; Dembitsky W; Long JW; Ascheim DD; Tierney AR; Levitan RG; Watson JT; Meier P; Ronan NS; Shapiro PA; Lazar RM; Miller LW; Gupta L; Frazier OH; Desvigne-Nickens P; Oz MC; Poirier VL;
    N Engl J Med; 2001 Nov; 345(20):1435-43. PubMed ID: 11794191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insertion of a left ventricular assist device in patients without thorough transplant evaluations: a worthwhile risk?
    Williams M; Casher J; Joshi N; Hankinson T; Warren M; Oz M; Naka Y; Mancini D
    J Thorac Cardiovasc Surg; 2003 Aug; 126(2):436-41. PubMed ID: 12928641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation.
    Bull DA; Reid BB; Selzman CH; Mesley R; Drakos S; Clayson S; Stoddard G; Gilbert E; Stehlik J; Bader F; Kfoury A; Budge D; Eckels DD; Fuller A; Renlund D; Patel AN
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):169-73. PubMed ID: 20451930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late right heart failure during support with continuous-flow left ventricular assist devices adversely affects post-transplant outcome.
    Takeda K; Takayama H; Colombo PC; Jorde UP; Yuzefpolskaya M; Fukuhara S; Mancini DM; Naka Y
    J Heart Lung Transplant; 2015 May; 34(5):667-74. PubMed ID: 25577566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survival.
    Tsukashita M; Takayama H; Takeda K; Han J; Colombo PC; Yuzefpolskaya M; Topkara VK; Garan AR; Mancini DM; Kurlansky PA; Naka Y
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1352-60, 1361.e1-2. PubMed ID: 26253875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgical therapy of end-stage heart failure. State of the art 2006].
    Klotz S; Loeher A; Drees G; Scheld HH
    Herz; 2006 Aug; 31(5):445-54. PubMed ID: 16944064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of ventricular assist device as bridge to simultaneous heart and kidney transplantation in patients with cardiac and renal failure.
    Yanagida R; Czer LS; Ruzza A; Schwarz ER; Simsir SA; Jordan SC; Trento A
    Transplant Proc; 2013; 45(6):2378-83. PubMed ID: 23953551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced heart failure patients supported with ambulatory inotropic therapy: What defines success of therapy?
    Grubb CS; Truby LK; Topkara VK; Bohnen MS; Yuzefpolskaya M; DeFilippis EM; Kleet A; Nakagawa S; Haythe JH; Axsom K; Colombo P; Takeda K; Uriel N; Sayer G; Garan H; Naka Y; Farr M
    Am Heart J; 2021 Sep; 239():11-18. PubMed ID: 33984317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular assist stand-by for high-risk cardiac surgery.
    Schmid C; Welp H; Klotz S; Trösch F; Schmidt C; Wilhelm MJ; Scheld HH
    Thorac Cardiovasc Surg; 2002 Dec; 50(6):342-6. PubMed ID: 12457310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year clinical experience with the Acorn CorCap cardiac support device: results of a limited market release safety study in Italy and Sweden.
    Livi U; Alfieri O; Vitali E; Russo C; Frigerio M; Tursi V; Albanese MC; De Bonis M; Fragasso G; Franco-Cereceda A; Forssell G; Rorke R; Kubo SH
    Ital Heart J; 2005 Jan; 6(1):59-65. PubMed ID: 15773275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative right ventricular assist device implantation technique for patients with perioperative right ventricular failure.
    Saeed D; Maxhera B; Kamiya H; Lichtenberg A; Albert A
    J Thorac Cardiovasc Surg; 2015 Mar; 149(3):927-32. PubMed ID: 25433641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.